Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.
Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.